Max Healthcare plays a significant role in combating Covid 19 in Delhi and Mumbai. Treats over 8,000 Covid patients, pioneers…
New Delhi, August 04, 2020: Wockhardt, the global pharmaceutical and biotechnology major today announced that it has entered into an…
Mumbai, June 15, 2019: At a meeting held in Mumbai today, the Board of Directors of Novartis India Limited announced…
The Development Operations Centre supports the development of AstraZeneca’s innovative medicines and hosts clinical trial experts focused on core therapeutic…
Shanghai, May 22, 2019: STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – and Dizal Pharmaceutical,…
Unnati Healthcare 2.0 is a multi-partner initiative with a shared vision of encouraging innovative solutions that can impact the treatment…
New Delhi, November 24, 2018: The report titled “Kuwait Pharmaceuticals Market Outlook to 2022 – By Type of Drugs (Generic…
New Delhi, August 18, 2018: Drug firm AstraZeneca Pharma India today said it has received permission from the Drug Controller General of India (DCGI) to import and market olaparib tablets…
Durvalumabis the only immunotherapy approved for patients with unresectable Stage III Non-Small Cell Lung Cancer (NSCLC) Durvalumabwas granted US FDA…
GMD India will support AstraZeneca’s global established medicines portfolio; build capabilities in regulatory science, and clinical and patient safety Bengaluru,…